U.S Class(es): 005, 006, 018, 044, 046, 051, 052
Class Status: Active
First Use: Jan-15-2017
First Use in Commerce: Feb-12-2017
Name | PROCCOR Pharmaceuticals Inc |
---|---|
Address | PO BOX 46846 Tampa FL 33646 |
Date | Description | Action Tags | Code |
---|---|---|---|
Jun-21-2022 | NEW APPLICATION ENTERED | NWAPI | |
Jul-06-2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | NWOSI | |
Mar-21-2023 | ASSIGNED TO EXAMINER | DOCKD | |
Mar-21-2023 | NON-FINAL ACTION WRITTEN | CNRTR | |
Mar-21-2023 | NON-FINAL ACTION E-MAILED | GNRTF | |
Mar-21-2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED | GNRNO | |
Mar-23-2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED | TROAI | |
Jul-31-2023 | ASSIGNED TO LIE | ALIEA | |
Aug-01-2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE | CRFAI | |
Aug-01-2023 | TEAS/EMAIL CORRESPONDENCE ENTERED | TEMEI | |
Aug-01-2023 | APPROVED FOR PUB - PRINCIPAL REGISTER | CNSAO | |
Aug-16-2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | NONPE | |
Sep-05-2023 | PUBLISHED FOR OPPOSITION | PUBOA | |
Sep-05-2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | NPUBE | |
Nov-21-2023 | REGISTERED-PRINCIPAL REGISTER | R.PRA | |
Nov-21-2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED | NRCCE |